PPARA is related to nonalcoholic fatty liver disease because deficiency in PPARA leads to lipid accumulation in the liver and researchers have proposed up‐regulation of its activity may be an effective treatment for nonalcoholic fatty liver disease (Pawlak et al., 2015). The gene discussed is PPARA; the disease is metabolic dysfunction-associated steatotic liver disease.